These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 33541866

  • 1. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
    Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Fracanzani AL, Aller R, Rosso C, Ampuero J, Gallego-Durán R, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Birolo G, Fariselli P, Eslam M, Valenti L, George J, Romero-Gómez M, Anstee QM, Bugianesi E.
    Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
    [Abstract] [Full Text] [Related]

  • 2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S.
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [Abstract] [Full Text] [Related]

  • 3. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH.
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [Abstract] [Full Text] [Related]

  • 4. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U, Yesil A, Yilmaz Y.
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
    Semmler G, Wernly S, Bachmayer S, Wernly B, Schwenoha L, Huber-Schönauer U, Stickel F, Niederseer D, Aigner E, Datz C.
    Clin Transl Gastroenterol; 2021 Apr 05; 12(4):e00326. PubMed ID: 33821832
    [Abstract] [Full Text] [Related]

  • 6. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M.
    J Gastroenterol Hepatol; 2016 Sep 05; 31(9):1611-8. PubMed ID: 26946071
    [Abstract] [Full Text] [Related]

  • 7. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W, Charatcharoenwitthaya N, Charatcharoenwitthaya P.
    Ann Hepatol; 2024 Sep 05; 29(3):101288. PubMed ID: 38278181
    [Abstract] [Full Text] [Related]

  • 8. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
    Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, Huber-Schönauer U, Niederseer D, Stickel F, Auer S, Haschke-Becher E, Patsch W, Datz C, Aigner E.
    Am J Gastroenterol; 2017 Jan 05; 112(1):102-110. PubMed ID: 27527746
    [Abstract] [Full Text] [Related]

  • 9. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects.
    Feldman A, Wernly B, Strebinger G, Eder SK, Zandanell S, Niederseer D, Strasser M, Haufe H, Sotlar K, Paulweber B, Datz C, Aigner E.
    J Gastrointestin Liver Dis; 2021 Sep 21; 30(3):366-373. PubMed ID: 34375373
    [Abstract] [Full Text] [Related]

  • 10. Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    Hirose S, Matsumoto K, Tatemichi M, Tsuruya K, Anzai K, Arase Y, Shiraishi K, Suzuki M, Ieda S, Kagawa T.
    PLoS One; 2020 Sep 21; 15(11):e0241770. PubMed ID: 33186403
    [Abstract] [Full Text] [Related]

  • 11. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
    Niriella MA, Kasturiratne A, Pathmeswaran A, De Silva ST, Perera KR, Subasinghe SKCE, Kodisinghe SK, Piyaratna TACL, Vithiya K, Dassanayaka AS, De Silva AP, Wickramasinghe AR, Takeuchi F, Kato N, de Silva HJ.
    Hepatol Int; 2019 May 21; 13(3):314-322. PubMed ID: 30539516
    [Abstract] [Full Text] [Related]

  • 12. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M, Jha AN, Sharma DJ.
    J Assoc Physicians India; 2022 Apr 21; 70(4):11-12. PubMed ID: 35443531
    [Abstract] [Full Text] [Related]

  • 13. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH.
    World J Gastroenterol; 2014 Dec 21; 20(47):17932-40. PubMed ID: 25548491
    [Abstract] [Full Text] [Related]

  • 14. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N, Zhou J, Wang K, Li X, Li Z.
    BMJ Open Diabetes Res Care; 2023 Feb 21; 11(1):. PubMed ID: 36792168
    [Abstract] [Full Text] [Related]

  • 15. Dietary inflammatory impact on NAFLD development in obese vs. lean individuals: an analysis based on NHANES 2003-2018.
    Li L, Shu X, Yi Y, Wang C, Li J, Ding Y, Li J, Chang Y.
    Lipids Health Dis; 2024 Apr 29; 23(1):127. PubMed ID: 38685122
    [Abstract] [Full Text] [Related]

  • 16. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A, Henson JB, Osganian SA, Nath C, Steinhagen LM, Memel ZN, Donovan A, Balogun O, Chung RT, Simon TG, Corey KE.
    Hepatol Commun; 2022 Feb 29; 6(2):309-319. PubMed ID: 34558862
    [Abstract] [Full Text] [Related]

  • 17. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
    Li MR, Li JZ, Li JY, Wang CC, Yuan RK, Ye LH, Liu YY, Liang XJ, Zhang HC, Liu ZQ, Zeng DY, Zhang XD, Wang DH, Li JQ, Li TY, Yang L, Cao Y, Pan Y, Lin XG, Pan CQ, Dai EH, Dong ZY.
    Obes Facts; 2023 Feb 29; 16(5):427-434. PubMed ID: 37231905
    [Abstract] [Full Text] [Related]

  • 18. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
    Ahmed OT, Gidener T, Mara KC, Larson JJ, Therneau TM, Allen AM.
    Clin Gastroenterol Hepatol; 2022 Jun 29; 20(6):1374-1381.e6. PubMed ID: 34265444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.